£41.40

Birkhauser ACE Inhibitors (Milestones in Drug Therapy)

Price data last checked 26 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£41 today · all-time low £41 (May 2026) · usually £41

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days · 65 data points (no recent data)

Historical
Generating forecast…
£41.72 £41.14 £41.26 £41.39 £41.52 £41.65 £41.77 26 April 2026 12 May 2026 28 May 2026 13 June 2026 29 June 2026

Price Distribution

Price distribution over 65 days • 2 price levels

Days at Price
Current Price
63 days · current 2 days · current 0 16 32 47 63 £41 £42 Days at Price

Price Analysis

Most common price: £41 (63 days, 96.9%)

Price range: £41 - £42

Price levels: 2 different prices over 65 days

Description

Angiotensin converting enzyme inhibitors (ACEI) represent the first class of antihypertensive agents that was designed and developed on the basis of a well-defined physiopathological axis of arterial hypertension, a vascular dis order that is now becoming one of the major causes of morbidity/mortality, not only in developed societies but also in the highly populated developing coun tries [1]. CAPTOPRIL, the prototype of the "PRIL" family, which now comprises more than 40 molecule-species, was quite hazardous and the clinical develop ment almost failed when serious side-effects were reported in an alarmist fash ion in reputable scientific journals, such as the New England Journal of Medicine and Lancet. Squibb & Sons came very close to withdrawing CAPTOPRIL from clinical investigation [2]. However, after re-examination of the data obtained from different categories of patients and appropriate dose-adjustments, the clinical use of CAPTOPRIL turned out to be revolutionary. The prototype, as well as other members of the "PRIL" family became the starting point for numerous basic and clinical research programs, focusing on the interactions of ACEI with the kinin, endothelin, and nitric oxide systems, and the contribution of the receptors for AT I, AT 2, bradykinin Bland B , ETA and ET B to the pharmacological actions 2 of the respective peptides. This research activity led to the development of new pharmacological agents, such as the angiotensin receptor antagonists and, more recently, the neutral endopeptidase inhibitors. In the near future, bradykinin receptor antagonists also will be available to modulate ACEI phar macological actions.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
18 September 2012
Listed Since
17 July 2013

Barcode

No barcode data available

Similar Products You Might Like

ACE Inhibitors: Medical Uses and Mechanisms - Volume 1
97% match

ACE Inhibitors: Medical Uses and Mechanisms - Volume 1

£96.83 02 Jul 2026
ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 1
97% match

ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 1

Nova Science Publishers Inc

£84.99 01 Jul 2026
Angiotensin II - Antagonismus: Ein neuer Weg zur Hochdruckbehandlung
97% match

Angiotensin II - Antagonismus: Ein neuer Weg zur Hochdruckbehandlung

Springer

£46.99 08 Jul 2026
Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology)
97% match

Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology)

Springer

£227.73 13 Jul 2026
Angiotensin-Converting Enzyme: Functions and Role in Disease (Biochemistry Research Trends)
97% match

Angiotensin-Converting Enzyme: Functions and Role in Disease (Biochemistry Research Trends)

£203.99 03 Jul 2026
Angiotensin Receptor Blockers & ACE Inhibitors: Role as Anti-inflammatory Agents
96% match

Angiotensin Receptor Blockers & ACE Inhibitors: Role as Anti-inflammatory Agents

LAP Lambert Academic Publishing

£47.00 04 Jul 2026
New Targets for the Treatment of Hypertension and Associated Diseases: Volume 94 (Advances in Pharmacology, Volume 94)
96% match

New Targets for the Treatment of Hypertension and Associated Diseases: Volume 94 (Advances in Pharmacology, Volume 94)

Academic Press

£152.88 30 Jun 2026
Bluthochdruck (Kliniktaschenbücher)
96% match

Bluthochdruck (Kliniktaschenbücher)

Springer

£45.50 08 Jul 2026
Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases
96% match

Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases

Springer

£107.47 08 Jul 2026
Therapie mit Antihypertensiva
96% match

Therapie mit Antihypertensiva

Springer

£43.09 08 Jul 2026
Atlas of Hypertension (Atlas of Heart Diseases)
96% match

Atlas of Hypertension (Atlas of Heart Diseases)

Springer

£53.82 15 Jul 2026
A Century of Arterial Hypertension, 1896-1996
96% match

A Century of Arterial Hypertension, 1896-1996

Wiley-Blackwell

Price unavailable
Springer - Angiotensin Receptors: Cellular and Molecular Aspects
96% match

Springer - Angiotensin Receptors: Cellular and Molecular Aspects

Springer

£108.77 15 Jul 2026
Renin Angiotensin System and Cardiovascular Disease (Contemporary Cardiology)
96% match

Renin Angiotensin System and Cardiovascular Disease (Contemporary Cardiology)

Humana

£80.64 20 Jun 2026
Antihypertensive Agents: 39 (Handbook of Experimental Pharmacology, 39)
96% match

Antihypertensive Agents: 39 (Handbook of Experimental Pharmacology, 39)

Springer

£77.59 04 Jul 2026
Hypertension: Methods and Protocols: 1527 (Methods in Molecular Biology, 1527)
96% match

Hypertension: Methods and Protocols: 1527 (Methods in Molecular Biology, 1527)

Humana

£104.18 15 Jul 2026
Amlodipine
96% match

Amlodipine

Springer

£84.67 02 Jul 2026
Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases
95% match

Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases

Springer

£137.61 13 Jul 2026
Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors: 396 (Advances in Experimental Medicine and Biology, 396)
95% match

Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors: 396 (Advances in Experimental Medicine and Biology, 396)

Springer

£113.39 15 Jul 2026
Pulmonary Hypertension, An Issue of Cardiology Clinics: Volume 40-1 (The Clinics: Internal Medicine, Volume 40-1)
95% match

Pulmonary Hypertension, An Issue of Cardiology Clinics: Volume 40-1 (The Clinics: Internal Medicine, Volume 40-1)

Elsevier

£65.98 09 Jul 2026
Hypertension: New Frontiers: A Textbook of Cardiology
95% match

Hypertension: New Frontiers: A Textbook of Cardiology

Jaypee Brothers Medical Publishers

£234.39 20 Jun 2026
Hypertension, Heredity and Stroke - Cerebrovascular Research
95% match

Hypertension, Heredity and Stroke - Cerebrovascular Research

£120.54 15 Jul 2026
Interventional Therapies for Secondary and Essential Hypertension (Updates in Hypertension and Cardiovascular Protection)
95% match

Interventional Therapies for Secondary and Essential Hypertension (Updates in Hypertension and Cardiovascular Protection)

Springer

£87.45 07 Jul 2026
Interventional Therapies for Secondary and Essential Hypertension (Updates in Hypertension and Cardiovascular Protection)
95% match

Interventional Therapies for Secondary and Essential Hypertension (Updates in Hypertension and Cardiovascular Protection)

Springer

£88.34 14 Jul 2026